Mechanism of Action Tumour necrosis factor ligand superfamily member 15 inhibitors Orphan Drug Status Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases. No New Molecular Entity Yes Highest Development Phases Phase III Crohn's disease;...